These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32018269)

  • 1. Prediction of Perinatal Mortality in Ebstein's Anomaly Diagnosed in the Second Trimester of Pregnancy.
    Masoller N; Gómez Del Rincón O; Herraiz I; Gómez-Montes E; Soveral I; Pérez-Cruz M; Martínez-Biosques C; Granados MA; Bennasar M; Escobar-Diaz MC; Martínez JM; Galindo A
    Fetal Diagn Ther; 2020; 47(8):604-614. PubMed ID: 32018269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal echocardiographic prediction score for perinatal mortality in tricuspid valve dysplasia and Ebstein's anomaly.
    Torigoe F; Ishida H; Ishii Y; Ishii R; Narita J; Kawazu Y; Kayatani F; Inamura N
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):226-232. PubMed ID: 31008542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes following early prenatal diagnosis: insights from a single-center experience with Ebstein anomaly and tricuspid valve dysplasia.
    Dedeoglu R; Akbulut DG; Turkmen E; Dedeoglu S; Bornaun H
    Arch Gynecol Obstet; 2024 Sep; 310(3):1491-1497. PubMed ID: 38683395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.
    Freud LR; Escobar-Diaz MC; Kalish BT; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; McElhinney DB; Tworetzky W
    Circulation; 2015 Aug; 132(6):481-9. PubMed ID: 26059011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-gestation prediction of outcome in tricuspid valve dysplasia and Ebstein's anomaly using fetal tricuspid regurgitation waveform analysis.
    Ikegawa T; Kim KS; Kawataki M; Ichikawa Y; Ono S; Yanagi S; Ueda H
    Ultrasound Obstet Gynecol; 2023 May; 61(5):593-600. PubMed ID: 36273401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebstein's anomaly and tricuspid valve dysplasia: prognosis after diagnosis in utero.
    Barre E; Durand I; Hazelzet T; David N
    Pediatr Cardiol; 2012 Dec; 33(8):1391-6. PubMed ID: 22639000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fetal diagnosis and prognosis of Ebstein's anomaly].
    Luis-Miranda RS; Arias-Monroy LG; Alcantar-Mendoza MA; Arroyo CC; Reyes EM; Jarer SC
    Ginecol Obstet Mex; 2013 May; 81(5):221-30. PubMed ID: 23819422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular function and geometry in fetuses with severe tricuspid regurgitation.
    Ishii T; Tworetzky W; Harrild DM; Marcus EN; McElhinney DB
    Ultrasound Obstet Gynecol; 2012 Jul; 40(1):55-61. PubMed ID: 21997973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetus.
    Lasa JJ; Tian ZY; Guo R; Rychik J
    Prenat Diagn; 2012 Mar; 32(3):245-51. PubMed ID: 22430722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.
    Freud LR; McElhinney DB; Kalish BT; Escobar-Diaz MC; Komarlu R; Puchalski MD; Jaeggi ET; Szwast AL; Freire G; Levasseur SM; Kavanaugh-McHugh A; Michelfelder EC; Moon-Grady AJ; Donofrio MT; Howley LW; Selamet Tierney ES; Cuneo BF; Morris SA; Pruetz JD; van der Velde ME; Kovalchin JP; Ikemba CM; Vernon MM; Samai C; Satou GM; Gotteiner NL; Phoon CK; Silverman NH; Tworetzky W
    J Am Heart Assoc; 2020 Nov; 9(21):e016684. PubMed ID: 33076749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Outcomes and Factors Associated With Mortality After a Fetal or Neonatal Diagnosis of Ebstein Anomaly and Tricuspid Valve Disease.
    Wertaschnigg D; Manlhiot C; Jaeggi M; Seed M; Dragulescu A; Schwartz SM; van Arsdell G; Jaeggi ET
    Can J Cardiol; 2016 Dec; 32(12):1500-1506. PubMed ID: 27476984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prenatal haemodynamic and functional abnormalities in Ebstein's anomaly on survival.
    Freire G; Nguyen T; Sekar P; Wilhm M; Arnold K; Leshko J; Amankwah EK; Huhta J
    Cardiol Young; 2014 Dec; 24(6):1049-56. PubMed ID: 25647378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between echocardiographic and morphological investigations of lesions of the tricuspid valve diagnosed during fetal life.
    Oberhoffer R; Cook AC; Lang D; Sharland G; Allan LD; Fagg NL; Anderson RH
    Br Heart J; 1992 Dec; 68(6):580-5. PubMed ID: 1467052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the prognosis of Ebstein's anomaly during fetal life.
    Pavlova M; Fouron JC; Drblik SP; van Doesburg NH; Bigras JL; Smallhorn J; Harder J; Robertson M
    Am Heart J; 1998 Jun; 135(6 Pt 1):1081-5. PubMed ID: 9630115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome.
    Hornberger LK; Sahn DJ; Kleinman CS; Copel JA; Reed KL
    J Am Coll Cardiol; 1991 Jan; 17(1):167-73. PubMed ID: 1987222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and prognosis of fetal ebstein anomaly].
    Luis-Miranda RS; Arias-Mon-roy LG; Alcantar-Mendoza MA; Cabrera-Arroyo C; Mendoza-Reyes E; Jarero SC
    Ginecol Obstet Mex; 2014 Feb; 82(2):93-104. PubMed ID: 24779265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal and postnatal ultrasound assessment and clinical prognostic analysis for Ebstein anomaly].
    Liu XR; Ding WW; Yang J; Mo Y; Shi WM
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):465-470. PubMed ID: 31216805
    [No Abstract]   [Full Text] [Related]  

  • 18. Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly.
    Wald RM; Adatia I; Van Arsdell GS; Hornberger LK
    Am J Cardiol; 2005 Sep; 96(6):851-6. PubMed ID: 16169376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Assessment of Left Ventricular Dysfunction in Fetal Ebstein's Anomaly and Tricuspid Valve Dysplasia.
    Eckersley LG; Howley LW; van der Velde ME; Khoo NS; Mah K; Brooks P; Colen T; Hornberger LK
    J Am Soc Echocardiogr; 2019 Dec; 32(12):1598-1607. PubMed ID: 31551185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebstein's anomaly: epidemiological analysis and presentation of different prenatal management.
    Rydzewska K; Sylwestrzak O; Krekora M; Słodki M; Respondek-Liberska M
    J Matern Fetal Neonatal Med; 2022 Sep; 35(17):3297-3304. PubMed ID: 32933366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.